US129584A
(en)
*
|
|
1872-07-16 |
|
Improvement in springs for gates and doors |
US134351A
(en)
*
|
|
1872-12-31 |
|
Improvement in crutches |
US175694A
(en)
*
|
|
1876-04-04 |
|
Improvement in sponge-cups |
US129203A
(en)
*
|
|
1872-07-16 |
|
Improvement in animal-traps |
US3171820A
(en)
*
|
1964-02-17 |
1965-03-02 |
Scott Paper Co |
Reticulated polyurethane foams and process for their production
|
US3224404A
(en)
*
|
1964-11-06 |
1965-12-21 |
Jong George E De |
Mooring device
|
GB1429184A
(en)
*
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
US4044126A
(en)
*
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
US4302386A
(en)
*
|
1978-08-25 |
1981-11-24 |
The Ohio State University |
Antigenic modification of polypeptides
|
US4363877B1
(en)
*
|
1977-09-23 |
1998-05-26 |
Univ California |
Recombinant dna transfer vectors
|
US5221619A
(en)
*
|
1977-11-08 |
1993-06-22 |
Genentech, Inc. |
Method and means for microbial polypeptide expression
|
US4503035B1
(en)
*
|
1978-11-24 |
1996-03-19 |
Hoffmann La Roche |
Protein purification process and product
|
US4342832A
(en)
*
|
1979-07-05 |
1982-08-03 |
Genentech, Inc. |
Method of constructing a replicable cloning vehicle having quasi-synthetic genes
|
US4898830A
(en)
*
|
1979-07-05 |
1990-02-06 |
Genentech, Inc. |
Human growth hormone DNA
|
US5510472A
(en)
*
|
1979-11-21 |
1996-04-23 |
Yeda Research And Development Co. Ltd. |
Production of recombinant human interferon-beta2
|
US4816396A
(en)
*
|
1980-03-10 |
1989-03-28 |
Cetus Corporation |
Method and vector organism for controlled accumulation of heterologous gene products in bacillus subtilis
|
US6610830B1
(en)
|
1980-07-01 |
2003-08-26 |
Hoffman-La Roche Inc. |
Microbial production of mature human leukocyte interferons
|
US4462985A
(en)
|
1980-08-22 |
1984-07-31 |
University Of Illinois Foundation |
Delivery of biologically active components of heterologous species interferon isolates
|
US4678751A
(en)
*
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
US4775622A
(en)
*
|
1982-03-08 |
1988-10-04 |
Genentech, Inc. |
Expression, processing and secretion of heterologous protein by yeast
|
US4670393A
(en)
*
|
1982-03-22 |
1987-06-02 |
Genentech, Inc. |
DNA vectors encoding a novel human growth hormone-variant protein
|
US4446235A
(en)
*
|
1982-03-22 |
1984-05-01 |
Genentech, Inc. |
Method for cloning human growth hormone varient genes
|
US4665160A
(en)
*
|
1982-03-22 |
1987-05-12 |
Genentech, Inc. |
Novel human growth hormone like protein HGH-V encoded in the human genome
|
DE3220116A1
(de)
*
|
1982-05-28 |
1983-12-01 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Mikrobiologisch hergestellte (alpha)- und ss-interferone, dna-sequenzen, die fuer diese interferone codieren, mikroorganismen, die diese genetische information enthalten, und verfahren zu ihrer herstellung
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
US4588585A
(en)
*
|
1982-10-19 |
1986-05-13 |
Cetus Corporation |
Human recombinant cysteine depleted interferon-β muteins
|
US5618697A
(en)
*
|
1982-12-10 |
1997-04-08 |
Novo Nordisk A/S |
Process for preparing a desired protein
|
US4820515A
(en)
|
1982-12-13 |
1989-04-11 |
Texas A&M University System |
Method of using interferon in low dosage to regulate appetite and efficiency of food utilization
|
US4497795A
(en)
|
1982-12-13 |
1985-02-05 |
The Texas A&M University System |
Method of regulating appetite and efficiency of food utilization employing interferon
|
US5910304A
(en)
|
1982-12-13 |
1999-06-08 |
Texas A&M University System |
Low-dose oral administration of interferons
|
US4518584A
(en)
*
|
1983-04-15 |
1985-05-21 |
Cetus Corporation |
Human recombinant interleukin-2 muteins
|
US4859600A
(en)
*
|
1983-04-25 |
1989-08-22 |
Genentech, Inc. |
Recombinant procaryotic cell containing correctly processed human growth hormone
|
US4755465A
(en)
*
|
1983-04-25 |
1988-07-05 |
Genentech, Inc. |
Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
|
GB8317880D0
(en)
|
1983-07-01 |
1983-08-03 |
Searle & Co |
Structure and synthesis of interferons
|
US5256546A
(en)
*
|
1983-07-15 |
1993-10-26 |
Bio-Technology General Corp. |
Bacterial expression of porcine growth hormone
|
BG49718A3
(en)
*
|
1983-07-15 |
1992-01-15 |
Bio Technology General Corp |
Method for preparing of polypeptid with superoxiddismutasne activitty
|
US5198361A
(en)
*
|
1983-07-15 |
1993-03-30 |
Bio-Technology General Corp. |
Plasmids for production of met-asp-gln bovine growth hormone, hosts containing the plasmids, products manufactured thereby and related methods
|
US5637495A
(en)
*
|
1983-07-15 |
1997-06-10 |
Bio-Technology General Corp. |
Plasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methods
|
US5670371A
(en)
*
|
1983-07-15 |
1997-09-23 |
Bio-Technology General Corp. |
Bacterial expression of superoxide dismutase
|
US4703008A
(en)
*
|
1983-12-13 |
1987-10-27 |
Kiren-Amgen, Inc. |
DNA sequences encoding erythropoietin
|
KR850004274A
(ko)
*
|
1983-12-13 |
1985-07-11 |
원본미기재 |
에리트로포이에틴의 제조방법
|
NZ210501A
(en)
*
|
1983-12-13 |
1991-08-27 |
Kirin Amgen Inc |
Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence
|
GB8412564D0
(en)
*
|
1984-05-17 |
1984-06-20 |
Searle & Co |
Structure and properties
|
US4747825A
(en)
*
|
1984-06-29 |
1988-05-31 |
Ferring Laboratories, Inc. |
Apparatus and methodology for pulsed administration of growth promoting agents
|
US4937076A
(en)
|
1984-08-10 |
1990-06-26 |
Combe Incorporated |
Chewable aspirin and buffering material tablet and method for producing same
|
US4797368A
(en)
*
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
DE3588239T3
(de)
*
|
1985-03-30 |
2007-03-08 |
Kauffman, Stuart A., Santa Fe |
Verfahren zum Erhalten von DNS, RNS, Peptiden, Polypeptiden oder Proteinen durch DMS-Rekombinant-Verfahren
|
US5198345A
(en)
*
|
1985-04-15 |
1993-03-30 |
Gist-Brocades N.V. |
Vectors in use in filamentous fungi
|
US4845196A
(en)
*
|
1985-06-24 |
1989-07-04 |
G. D. Searle & Co. |
Modified interferon gammas
|
US5391485A
(en)
*
|
1985-08-06 |
1995-02-21 |
Immunex Corporation |
DNAs encoding analog GM-CSF molecules displaying resistance to proteases which cleave at adjacent dibasic residues
|
US4810643A
(en)
*
|
1985-08-23 |
1989-03-07 |
Kirin- Amgen Inc. |
Production of pluripotent granulocyte colony-stimulating factor
|
US5631227A
(en)
*
|
1985-09-18 |
1997-05-20 |
The Upjohn Company |
Somatotropin analogs
|
US5139941A
(en)
*
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
IL77186A0
(en)
*
|
1985-11-29 |
1986-04-29 |
Touitou Elka |
Pharmaceutical insulin composition
|
US5298603A
(en)
*
|
1985-12-21 |
1994-03-29 |
Hoechst Aktiengesellschaft |
GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
|
US4820514A
(en)
|
1985-12-30 |
1989-04-11 |
Texas A&M University System |
Low dosage of interferon to enhance vaccine efficiency
|
US6548640B1
(en)
*
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
EP0240224A3
(de)
*
|
1986-03-31 |
1989-02-01 |
Interferon Sciences, Inc. |
Alpha-Interferon-Analogon
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
DK173067B1
(da)
*
|
1986-06-27 |
1999-12-13 |
Univ Washington |
Humant erythropoietin-gen, fremgangsmåde til ekspression deraf i transficerede cellelinier, de transficerede cellelinier sa
|
EP0260350B1
(de)
|
1986-09-05 |
1992-02-12 |
Cetus Oncology Corporation |
Oxidationsresistente Muteine von beta-Interferon, deren Herstellung und diese Muteine enthaltende Präparate
|
US5183746A
(en)
|
1986-10-27 |
1993-02-02 |
Schering Aktiengesellschaft |
Formulation processes for pharmaceutical compositions of recombinant β-
|
ZA878295B
(en)
|
1986-11-06 |
1988-05-03 |
Amarillo Cell Culture Co. Inc. |
Treatment of immuno-resistant disease
|
CA1320905C
(en)
|
1986-11-06 |
1993-08-03 |
Joseph M. Cummins |
Treatment of immuno-resistant disease
|
US5013718A
(en)
*
|
1986-11-21 |
1991-05-07 |
Amgen, Inc. |
Method for treating iron overload using EPO
|
US5214132A
(en)
*
|
1986-12-23 |
1993-05-25 |
Kyowa Hakko Kogyo Co., Ltd. |
Polypeptide derivatives of human granulocyte colony stimulating factor
|
US4835260A
(en)
*
|
1987-03-20 |
1989-05-30 |
Genetics Institute, Inc. |
Erythropoietin composition
|
US4904584A
(en)
*
|
1987-12-23 |
1990-02-27 |
Genetics Institute, Inc. |
Site-specific homogeneous modification of polypeptides
|
US5017371A
(en)
*
|
1988-01-06 |
1991-05-21 |
Amarillo Cell Culture Company, Incorporated |
Method for reducing side effects of cancer therapy
|
US5698418A
(en)
*
|
1988-02-17 |
1997-12-16 |
Pharmacia & Upjohn Company |
Fermentation media and methods for controlling norleucine in polypeptides
|
US5068317A
(en)
*
|
1988-03-15 |
1991-11-26 |
Eli Lilly And Company |
Novel derivative of human growth hormone
|
US5445826A
(en)
*
|
1988-06-28 |
1995-08-29 |
Cibus Pharmaceutical, Inc. |
Delivery system containing a gel-forming dietary fiber and a drug
|
CA1333777C
(en)
*
|
1988-07-01 |
1995-01-03 |
Randy M. Berka |
Aspartic proteinase deficient filamentous fungi
|
US5079345A
(en)
*
|
1988-08-19 |
1992-01-07 |
Eli Lilly And Company |
Proteins having growth hormone anabolic properties with reduced effect on carbohydrate metabolism
|
ES2154627T3
(es)
*
|
1988-08-24 |
2001-04-16 |
American Cyanamid Co |
Estabilizacion de somatotropinas mediante la modificacion de restos de cisteina utilizando mutagenesis de localizacion dirigida o derivatizacion quimica.
|
US5130422A
(en)
*
|
1988-08-29 |
1992-07-14 |
Monsanto Company |
Variant somatotropin-encoding DNA
|
US5089473A
(en)
*
|
1988-08-29 |
1992-02-18 |
Monsanto Company |
Somatotropin variants and their use
|
US5223409A
(en)
*
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
US5079230A
(en)
*
|
1988-09-12 |
1992-01-07 |
Pitman-Moore, Inc. |
Stable bioactive somatotropins
|
GB8824591D0
(en)
*
|
1988-10-20 |
1988-11-23 |
Royal Free Hosp School Med |
Fractionation process
|
US5534617A
(en)
*
|
1988-10-28 |
1996-07-09 |
Genentech, Inc. |
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
|
US5688666A
(en)
*
|
1988-10-28 |
1997-11-18 |
Genentech, Inc. |
Growth hormone variants with altered binding properties
|
DE68929151T2
(de)
*
|
1988-10-28 |
2000-07-20 |
Genentech Inc |
Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
|
US6780613B1
(en)
*
|
1988-10-28 |
2004-08-24 |
Genentech, Inc. |
Growth hormone variants
|
US5096815A
(en)
*
|
1989-01-06 |
1992-03-17 |
Protein Engineering Corporation |
Generation and selection of novel dna-binding proteins and polypeptides
|
US5101018A
(en)
*
|
1989-06-12 |
1992-03-31 |
International Minerals & Chemical Corp. |
Method for recovering recombinant proteins
|
US5663305A
(en)
*
|
1989-07-10 |
1997-09-02 |
The Upjohn Company |
Somatotropin analogs
|
DE3923963A1
(de)
*
|
1989-07-20 |
1991-01-31 |
Behringwerke Ag |
Muteine des menschlichen erythropoetins, ihre herstellung und ihre verwendung
|
US5047511A
(en)
*
|
1989-08-28 |
1991-09-10 |
Pitman-Moore, Inc. |
Method for recovering recombinant proteins
|
US5436146A
(en)
*
|
1989-09-07 |
1995-07-25 |
The Trustees Of Princeton University |
Helper-free stocks of recombinant adeno-associated virus vectors
|
US6583115B1
(en)
*
|
1989-10-12 |
2003-06-24 |
Ohio University/Edison Biotechnology Institute |
Methods for treating acromegaly and giantism with growth hormone antagonists
|
US5350836A
(en)
*
|
1989-10-12 |
1994-09-27 |
Ohio University |
Growth hormone antagonists
|
US5958879A
(en)
*
|
1989-10-12 |
1999-09-28 |
Ohio University/Edison Biotechnology Institute |
Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal
|
US6787336B1
(en)
*
|
1989-10-12 |
2004-09-07 |
Ohio University/Edison Biotechnology Institute |
DNA encoding growth hormone antagonists
|
US5856298A
(en)
*
|
1989-10-13 |
1999-01-05 |
Amgen Inc. |
Erythropoietin isoforms
|
JPH03151399A
(ja)
|
1989-11-07 |
1991-06-27 |
Snow Brand Milk Prod Co Ltd |
変異ヒトエリスロポエチン
|
EP0510082A1
(de)
*
|
1990-01-08 |
1992-10-28 |
Schering Corporation |
Oxidierte varianten von gm-csf
|
US4988798A
(en)
*
|
1990-01-22 |
1991-01-29 |
Pitman-Moore, Inc. |
Method for recovering recombinant proteins
|
US5109121A
(en)
*
|
1990-01-22 |
1992-04-28 |
Pitman-Moore, Inc. |
Method for recovering recombinant proteins
|
US5262568A
(en)
*
|
1990-03-02 |
1993-11-16 |
State Of Oregon |
Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
|
CA2079802C
(en)
*
|
1990-04-05 |
2001-09-18 |
Roberto Crea |
Walk-through mutagenesis
|
GB9107846D0
(en)
*
|
1990-04-30 |
1991-05-29 |
Ici Plc |
Polypeptides
|
US5951972A
(en)
*
|
1990-05-04 |
1999-09-14 |
American Cyanamid Company |
Stabilization of somatotropins and other proteins by modification of cysteine residues
|
US5399345A
(en)
*
|
1990-05-08 |
1995-03-21 |
Boehringer Mannheim, Gmbh |
Muteins of the granulocyte colony stimulating factor
|
HUT63185A
(en)
*
|
1990-06-04 |
1993-07-28 |
Schering Corp |
Process for producing crystalline alpha-2-interferon
|
US5849694A
(en)
*
|
1990-07-16 |
1998-12-15 |
Synenki; Richard M. |
Stable and bioactive modified porcine somatotropin and pharmaceutical compositions thereof
|
IE912365A1
(en)
*
|
1990-07-23 |
1992-01-29 |
Zeneca Ltd |
Continuous release pharmaceutical compositions
|
US5871974A
(en)
*
|
1990-09-28 |
1999-02-16 |
Ixsys Inc. |
Surface expression libraries of heteromeric receptors
|
US5770434A
(en)
*
|
1990-09-28 |
1998-06-23 |
Ixsys Incorporated |
Soluble peptides having constrained, secondary conformation in solution and method of making same
|
US6258530B1
(en)
*
|
1990-09-28 |
2001-07-10 |
Ixsys, Inc. |
Surface expression libraries of randomized peptides
|
US5215741A
(en)
*
|
1990-10-30 |
1993-06-01 |
Amarillo Cell Culture Company, Incorporated |
Method for prevention of parasite infections
|
CA2044468C
(en)
*
|
1990-11-21 |
2006-08-22 |
Richard A. Nash |
Canine granulocyte macrophage colony stimulating factor
|
NZ240718A
(en)
*
|
1990-11-30 |
1996-10-28 |
Bio Technology General Corp |
Somatotropin analogues carrying mutations in the alpha-helix-1 region
|
US5310882A
(en)
*
|
1990-11-30 |
1994-05-10 |
American Cyanamid Company |
Somatotropins with alterations in the α-helix 3 region
|
WO1992009690A2
(en)
*
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with altered binding properties
|
ES2087323T3
(es)
*
|
1991-02-19 |
1996-07-16 |
Takeda Chemical Industries Ltd |
Metodo para producir peptidos exentos de cisteina.
|
ATE196548T1
(de)
*
|
1991-05-10 |
2000-10-15 |
Genentech Inc |
Auswählen von agonisten und antagonisten von liganden
|
NZ245015A
(en)
*
|
1991-11-05 |
1995-12-21 |
Transkaryotic Therapies Inc |
Delivery of human growth hormone through the administration of transfected cell lines encoding human growth hormone, which are physically protected from host immune response; the transfected cells and their production
|
US5733761A
(en)
*
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
US5676942A
(en)
*
|
1992-02-10 |
1997-10-14 |
Interferon Sciences, Inc. |
Composition containing human alpha interferon species proteins and method for use thereof
|
JPH05289267A
(ja)
*
|
1992-04-07 |
1993-11-05 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料
|
US5614184A
(en)
*
|
1992-07-28 |
1997-03-25 |
New England Deaconess Hospital |
Recombinant human erythropoietin mutants and therapeutic methods employing them
|
US6153407A
(en)
*
|
1992-07-28 |
2000-11-28 |
Beth Israel Deaconess Medical Center |
Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
|
US6436387B1
(en)
*
|
1992-11-24 |
2002-08-20 |
G.D. Searle & Co. |
Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins
|
US5581476A
(en)
*
|
1993-01-28 |
1996-12-03 |
Amgen Inc. |
Computer-based methods and articles of manufacture for preparing G-CSF analogs
|
US5441734A
(en)
*
|
1993-02-25 |
1995-08-15 |
Schering Corporation |
Metal-interferon-alpha crystals
|
JPH08509614A
(ja)
*
|
1993-04-29 |
1996-10-15 |
アボツト・ラボラトリーズ |
エリスロポエチン類似体組成物および方法
|
EP0626448A3
(de)
*
|
1993-05-26 |
1998-01-14 |
BOEHRINGER INGELHEIM INTERNATIONAL GmbH |
Verfahren zur Herstellung und Reinigung von alpha-Interferon
|
JPH09501827A
(ja)
*
|
1993-06-11 |
1997-02-25 |
ペストカ バイオメディカル ラボラトリーズ インコーポレイテッド |
インターフェロンおよびインターロイキンを含む超タンパク質
|
US6299870B1
(en)
*
|
1993-06-11 |
2001-10-09 |
Pbl Biomedical Laboratories |
Mutant human interferons
|
SG52238A1
(en)
*
|
1993-07-28 |
1998-09-28 |
Medvet Science Pty Ltd |
Haemopoietic growth factor antagonists
|
US5424289A
(en)
*
|
1993-07-30 |
1995-06-13 |
Alza Corporation |
Solid formulations of therapeutic proteins for gastrointestinal delivery
|
US5798500A
(en)
*
|
1993-08-10 |
1998-08-25 |
Stillwagon, Jr.; Ross I. |
Curling iron stove with internal cavity with electric heater positioned therebelow
|
IL192290A0
(en)
|
1993-08-17 |
2008-12-29 |
Kirin Amgen Inc |
Erythropoietin analogs
|
US5976552A
(en)
*
|
1995-04-28 |
1999-11-02 |
Protein Sciences Corporation |
Virus vaccines
|
US5939534A
(en)
*
|
1993-12-29 |
1999-08-17 |
Sumitomo Pharmaceuticals Company, Limited |
Factors mutated in the D1 cap region
|
US5597709A
(en)
*
|
1994-01-27 |
1997-01-28 |
Human Genome Sciences, Inc. |
Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
|
US6335160B1
(en)
*
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
US5605793A
(en)
*
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
US6165793A
(en)
*
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
US6117679A
(en)
*
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
WO1995023165A1
(fr)
*
|
1994-02-23 |
1995-08-31 |
Kyowa Hakko Kogyo Co., Ltd. |
Accelerateur de croissance des thrombocytes
|
CA2183550A1
(en)
|
1994-03-04 |
1995-09-08 |
Craig M. Lewis |
In vitro antibody affinity maturation using alanine scanning mutagenesis
|
US5545723A
(en)
|
1994-03-15 |
1996-08-13 |
Biogen Inc. |
Muteins of IFN-β
|
US5747446A
(en)
*
|
1994-03-22 |
1998-05-05 |
Beth Israel Deaconess Medical Center |
Modified polypeptides with increased biological activity
|
US5580853A
(en)
*
|
1994-03-22 |
1996-12-03 |
New England Deaconess Hospital |
Modified polypeptides with increased biological activity
|
US6024734A
(en)
|
1994-03-31 |
2000-02-15 |
Brewitt; Barbara A. |
Treatment methods using homeopathic preparations of growth factors
|
US5635599A
(en)
*
|
1994-04-08 |
1997-06-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
Fusion proteins comprising circularly permuted ligands
|
US6346243B1
(en)
|
1994-04-12 |
2002-02-12 |
Research Development Foundation |
Inhibition of transplant rejection by type one interferon
|
JP3560639B2
(ja)
|
1994-05-26 |
2004-09-02 |
株式会社タカハシキカン |
焼却炉
|
FR2722208B1
(fr)
|
1994-07-05 |
1996-10-04 |
Inst Nat Sante Rech Med |
Nouveau site interne d'entree des ribosomes, vecteur le contenant et utilisation therapeutique
|
US5460232A
(en)
*
|
1994-07-25 |
1995-10-24 |
Central Mine Equipment Company |
Rotary earth drill bit socket shield
|
US6099830A
(en)
*
|
1994-08-09 |
2000-08-08 |
Zymogenetics, Inc. |
Methods for stimulating erythropoiesis using hematopoietic proteins
|
IL116085A
(en)
*
|
1994-12-16 |
1999-12-31 |
Ortho Pharma Corp |
Spray dried erythropoietin
|
IL116816A
(en)
*
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
US6387365B1
(en)
|
1995-05-19 |
2002-05-14 |
Schering Corporation |
Combination therapy for chronic hepatitis C infection
|
US5871723A
(en)
*
|
1995-06-06 |
1999-02-16 |
The Regent Of The University Of Michigan |
CXC chemokines as regulators of angiogenesis
|
US5814485A
(en)
|
1995-06-06 |
1998-09-29 |
Chiron Corporation |
Production of interferon-β (IFN-β) in E. coli
|
US5854049A
(en)
*
|
1995-06-09 |
1998-12-29 |
President And Fellows Of Harvard College |
Plasmin-resistant streptokinase
|
AUPN378095A0
(en)
*
|
1995-06-23 |
1995-07-20 |
Bresagen Limited |
Haemopoietic growth factor antagonists and uses therefor
|
NZ286884A
(en)
*
|
1995-06-29 |
1997-12-19 |
Mitsui Chemicals Inc |
Use of 20 kd human growth hormone in hrt, increasing serum igf-1 levels and stimulating lipolysis
|
US6057103A
(en)
*
|
1995-07-18 |
2000-05-02 |
Diversa Corporation |
Screening for novel bioactivities
|
DE19535853C2
(de)
*
|
1995-09-18 |
1999-04-01 |
Fraunhofer Ges Forschung |
Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
|
EP1568771A3
(de)
*
|
1995-09-21 |
2006-05-17 |
Genentech, Inc. |
Varianten des mensclichen Wachstumshormons
|
PT858343E
(pt)
|
1995-11-02 |
2004-07-30 |
Schering Corp |
Terapia por infusao continua de uma dose baixa de citoquina
|
US6171820B1
(en)
*
|
1995-12-07 |
2001-01-09 |
Diversa Corporation |
Saturation mutagenesis in directed evolution
|
US6479258B1
(en)
|
1995-12-07 |
2002-11-12 |
Diversa Corporation |
Non-stochastic generation of genetic vaccines
|
US6238884B1
(en)
*
|
1995-12-07 |
2001-05-29 |
Diversa Corporation |
End selection in directed evolution
|
US20030215798A1
(en)
*
|
1997-06-16 |
2003-11-20 |
Diversa Corporation |
High throughput fluorescence-based screening for novel enzymes
|
JP2000508521A
(ja)
|
1996-01-23 |
2000-07-11 |
バイロファーマ・インコーポレイテッド |
Rnaウイルス阻害剤の同定方法
|
AU723494B2
(en)
*
|
1996-02-13 |
2000-08-31 |
Jcr Pharmaceuticals Co., Ltd. |
Mutant human growth hormones and their uses
|
KR100394382B1
(ko)
|
1996-02-28 |
2004-02-05 |
유니하트 코포레이션 |
천연사람α-인터페론으로구성된약학조성물
|
US6096548A
(en)
*
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
IL126318A
(en)
*
|
1996-03-29 |
2004-09-27 |
Emisphere Tech Inc |
Compounds and compositions for delivering active agents and some novel carrier compounds
|
US6204022B1
(en)
*
|
1996-04-12 |
2001-03-20 |
Pepgen Corporation And University Of Florida |
Low-toxicity human interferon-alpha analogs
|
CN1151840C
(zh)
|
1996-05-09 |
2004-06-02 |
太平洋制药控股公司 |
干扰素在制备用于治疗哺乳动物肿瘤病的药剂中的应用
|
US6207145B1
(en)
|
1997-05-09 |
2001-03-27 |
Pharma Pacific Pty Ltd. |
Therapeutic applications of high dose interferon
|
IL126971A0
(en)
|
1996-05-09 |
1999-09-22 |
Pharma Pacific Pty Ltd |
Interferon compositions
|
US5763239A
(en)
*
|
1996-06-18 |
1998-06-09 |
Diversa Corporation |
Production and use of normalized DNA libraries
|
EP0874909A2
(de)
*
|
1996-08-23 |
1998-11-04 |
Arch Development Corporation |
Langzeitexpression von genprodukten bei transformierung der muskelzellen
|
WO1998013487A1
(en)
|
1996-09-27 |
1998-04-02 |
Maxygen, Inc. |
Methods for optimization of gene therapy by recursive sequence shuffling and selection
|
US6967092B1
(en)
*
|
1996-10-25 |
2005-11-22 |
Mc Kearn John P |
Multi-functional chimeric hematopoietic receptor agonists
|
DE19648625A1
(de)
*
|
1996-11-13 |
1998-05-14 |
Soft Gene Gmbh |
Mikroprojektil für das Einbringen von Substanzen in Zellen durch ballistischen Transfer
|
US5862514A
(en)
*
|
1996-12-06 |
1999-01-19 |
Ixsys, Inc. |
Method and means for synthesis-based simulation of chemicals having biological functions
|
BR9606270A
(pt)
|
1996-12-18 |
1998-09-22 |
Univ Minas Gerais |
Processo para a produção da proteína do interferon beta-cis humano recombinante e proteína de interferon beta-cis humano recombinante
|
US6884419B1
(en)
*
|
1996-12-23 |
2005-04-26 |
Kyowa Hakko Kogyo, Co., Ltd. |
hG-CSF fusion polypeptide having c-mpl activity, DNA coding for same and methods of treating anemia using same
|
US5779434A
(en)
|
1997-02-06 |
1998-07-14 |
Baker Hughes Incorporated |
Pump mounted thrust bearing
|
DE19717864C2
(de)
*
|
1997-04-23 |
2001-05-17 |
Fraunhofer Ges Forschung |
Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
|
US6153420A
(en)
*
|
1997-04-24 |
2000-11-28 |
Zymogenetics, Inc. |
Serine protease polypeptides and materials and methods for making them
|
WO1998050025A1
(fr)
*
|
1997-05-08 |
1998-11-12 |
Chugai Seiyaku Kabushiki Kaisha |
Agents prophylactiques et therapeutiques contre l'arteriosclerose
|
AU7383298A
(en)
*
|
1997-05-13 |
1998-12-08 |
Regents Of The University Of California, The |
Novel antiangiogenic peptide agents and their therapeutic and diagnostic use
|
US6165476A
(en)
*
|
1997-07-10 |
2000-12-26 |
Beth Israel Deaconess Medical Center |
Fusion proteins with an immunoglobulin hinge region linker
|
US7153943B2
(en)
*
|
1997-07-14 |
2006-12-26 |
Bolder Biotechnology, Inc. |
Derivatives of growth hormone and related proteins, and methods of use thereof
|
EP1881005B1
(de)
*
|
1997-07-14 |
2013-04-03 |
Bolder Biotechnology, Inc. |
Derivate von G-CSF und damit zusammenhängende Proteine
|
US7270809B2
(en)
*
|
1997-07-14 |
2007-09-18 |
Bolder Biotechnology, Inc. |
Cysteine variants of alpha interferon-2
|
US6753165B1
(en)
*
|
1999-01-14 |
2004-06-22 |
Bolder Biotechnology, Inc. |
Methods for making proteins containing free cysteine residues
|
WO1999012969A1
(en)
*
|
1997-09-08 |
1999-03-18 |
Metabolic Pharmaceuticals Ltd. |
Treatment of obesity
|
US6156509A
(en)
*
|
1997-11-12 |
2000-12-05 |
Genencor International, Inc. |
Method of increasing efficiency of directed evolution of a gene using phagemid
|
US6897297B1
(en)
*
|
1997-12-03 |
2005-05-24 |
Curis, Inc. |
Hydrophobically-modified protein compositions and methods
|
US6165458A
(en)
*
|
1997-12-26 |
2000-12-26 |
Pharmaderm Laboratories Ltd. |
Composition and method for dermal and transdermal administration of a cytokine
|
US6274158B1
(en)
*
|
1998-02-04 |
2001-08-14 |
Veronica L. Zaharia Czeizler |
Treatment with recombinant human erythropoietin of bleeding in patients with normal and abnormal hemostasis
|
DE69825137T2
(de)
*
|
1998-02-23 |
2005-07-21 |
Cilag Ag International |
Liposomale Erythropoietin-Dispersion
|
US6036949A
(en)
*
|
1998-03-05 |
2000-03-14 |
Amarillo Biosciences, Inc. |
Treatment of fibromyalgia with low doses of interferon
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
US6174406B1
(en)
*
|
1998-04-09 |
2001-01-16 |
International Business Machines Corporation |
Bonding together surfaces
|
US6413776B1
(en)
|
1998-06-12 |
2002-07-02 |
Galapagos Geonomics N.V. |
High throughput screening of gene function using adenoviral libraries for functional genomics applications
|
CA2330527A1
(en)
*
|
1998-06-15 |
1999-12-23 |
Genzyme Transgenics Corporation |
Erythropoietin analog-human serum albumin fusion
|
US6472512B1
(en)
|
1998-07-21 |
2002-10-29 |
Human Genome Sciences, Inc. |
Keratinocyte derived interferon
|
SK287491B6
(sk)
|
1998-10-16 |
2010-11-08 |
Biogen Idec Ma Inc. |
Fúzne proteíny interferónu- beta-1a a ich použitie
|
PT1121156E
(pt)
*
|
1998-10-16 |
2006-05-31 |
Biogen Idec Inc |
Conjugados de polimeros de interferao-beta-1a e as suas utilizacoes
|
AUPP660698A0
(en)
*
|
1998-10-21 |
1998-11-12 |
University Of Queensland, The |
A method of protein engineering
|
WO2000032387A1
(en)
*
|
1998-11-25 |
2000-06-08 |
Amarillo Biosciences, Inc. |
Interferon-alpha mediated upregulation of aquaporin expression
|
EP1135493A2
(de)
*
|
1998-11-30 |
2001-09-26 |
Eli Lilly And Company |
Erythropoietische substanzen
|
US6171620B1
(en)
*
|
1999-04-27 |
2001-01-09 |
Health Research, Inc. |
Method of enhancing the efficacy of anti-tumor agents
|
US6555343B1
(en)
*
|
1999-05-07 |
2003-04-29 |
Genentech Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
US6831060B2
(en)
*
|
1999-05-07 |
2004-12-14 |
Genentech, Inc. |
Chimpanzee erythropoietin (CHEPO) polypeptides and nucleic acids encoding the same
|
US6946265B1
(en)
*
|
1999-05-12 |
2005-09-20 |
Xencor, Inc. |
Nucleic acids and proteins with growth hormone activity
|
US6514729B1
(en)
*
|
1999-05-12 |
2003-02-04 |
Xencor, Inc. |
Recombinant interferon-beta muteins
|
US6710025B1
(en)
*
|
1999-05-26 |
2004-03-23 |
The Brigham And Women's Hospital, Inc. |
Treatment of damaged tissue using agents that modulate the activity of alpha-smooth muscle actin
|
US6319691B1
(en)
*
|
1999-06-15 |
2001-11-20 |
Usa Universe Bioengineering, Inc. |
Fusion proteins comprising IFN-alpha2b and TM-alpha1
|
US6566329B1
(en)
*
|
1999-06-28 |
2003-05-20 |
Novo Nordisk A/S |
Freeze-dried preparation of human growth hormone
|
CZ299516B6
(cs)
*
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
KR100356140B1
(ko)
*
|
1999-07-08 |
2002-10-19 |
한미약품공업 주식회사 |
인간 과립구 콜로니 자극인자 변이체 및 이의 생산 방법
|
US7144574B2
(en)
*
|
1999-08-27 |
2006-12-05 |
Maxygen Aps |
Interferon β variants and conjugates
|
US6531122B1
(en)
*
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
EP1221976A4
(de)
|
1999-09-28 |
2003-12-03 |
Amarillo Biosciences Inc |
Ifn-gama in niedriger dosierung zur behandlung von erkrankungen
|
EP1238082A2
(de)
*
|
1999-10-07 |
2002-09-11 |
Maxygen, Inc. |
Interferon-alpha homologe
|
US20040002474A1
(en)
*
|
1999-10-07 |
2004-01-01 |
Maxygen Inc. |
IFN-alpha homologues
|
WO2001032711A2
(en)
|
1999-10-21 |
2001-05-10 |
Board Of Trustees Of The University Of Arkansas |
Adeno-associated virus aav rep78 major regulatory protein, mutants thereof and uses thereof
|
CA2388982A1
(en)
|
1999-11-05 |
2001-05-10 |
Novozymes A/S |
Microtiter plate (mtp) based high throughput screening (hts) assays
|
BR0015506A
(pt)
*
|
1999-11-12 |
2002-07-23 |
Maxygen Holdings Ltd |
Conjugados de interferon gama, métodos para sua preparação, composições farmacêuticas que compreendem ás moléculas e seu uso no tratamento de doenças
|
CA2393688A1
(en)
*
|
1999-12-09 |
2001-06-14 |
Chiron Corporation |
Method for administering a cytokine to the central nervous system and the lymphatic system
|
FR2802645B1
(fr)
|
1999-12-16 |
2002-03-08 |
Meillat Roland |
Methode d'evaluation de la performance d'un ensemble d'agents biologiques dans des cellules cibles vivantes et ses applications
|
US6555660B2
(en)
*
|
2000-01-10 |
2003-04-29 |
Maxygen Holdings Ltd. |
G-CSF conjugates
|
US6646110B2
(en)
*
|
2000-01-10 |
2003-11-11 |
Maxygen Holdings Ltd. |
G-CSF polypeptides and conjugates
|
AU2001238397A1
(en)
*
|
2000-02-17 |
2001-08-27 |
California Institute Of Technology |
Computationally targeted evolutionary design
|
AU780270B2
(en)
*
|
2000-02-23 |
2005-03-10 |
Association Francaise Contre Les Myopathies |
Treatment of immune diseases
|
FR2808804B1
(fr)
|
2000-05-09 |
2002-08-02 |
Nautilus Biotech |
Procede de determination du titre d'agents biologiques en temps reel dans des cellules cibles vivantes et ses applications
|
AU5649901A
(en)
*
|
2000-05-12 |
2001-11-20 |
Univ Wales Medicine |
Method for detecting growth hormone variations in humans, the variations and their uses
|
ES2290142T3
(es)
*
|
2000-05-16 |
2008-02-16 |
Bolder Biotechnology, Inc. |
Metodos para replegamiento de proteinas que contiene residuos de cisteina libre.
|
US7154958B2
(en)
*
|
2000-07-05 |
2006-12-26 |
Texas Instruments Incorporated |
Code division multiple access wireless system with time reversed space time block transmitter diversity
|
CN101676400A
(zh)
*
|
2000-07-31 |
2010-03-24 |
比洛克西治疗公司 |
在浮萍中表达生物活性多肽
|
EP1326825A2
(de)
*
|
2000-08-18 |
2003-07-16 |
Emisphere Technologies, Inc. |
Verbindungen und zusammensetzungen zur abgabe von wirkstoffen
|
WO2002015664A2
(en)
|
2000-08-23 |
2002-02-28 |
The New York Hospital Medical Center Of Queens |
Methods of preventing or treating west nile virus and other infections
|
FR2813314B1
(fr)
|
2000-08-25 |
2004-05-07 |
Biomethodes |
Procede de mutagenese dirigee massive
|
CA2421757A1
(en)
*
|
2000-09-08 |
2002-03-14 |
Massachusetts Institute Of Technology |
G-csf analog compositions and methods
|
US20020169290A1
(en)
|
2000-11-02 |
2002-11-14 |
Claus Bornaes |
New multimeric interferon beta polypeptides
|
US20030072737A1
(en)
*
|
2000-12-29 |
2003-04-17 |
Michael Brines |
Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs
|
US20060183197A1
(en)
*
|
2001-01-11 |
2006-08-17 |
Andersen Kim V |
Variant growth hormone molecules conjugated with macromolecules compounds
|
ATE399794T1
(de)
*
|
2001-02-06 |
2008-07-15 |
Merck Patent Gmbh |
Modifizierter granulozyten stimulierender factor (g-csf) mit verringerter immunogenität
|
BR0207015A
(pt)
*
|
2001-02-06 |
2004-07-06 |
Merck Patent Ges Mit Beschroen |
Eritropoientina modificada (epo) com imunogenicidade reduzida
|
PL362324A1
(en)
*
|
2001-02-19 |
2004-10-18 |
Merck Patent Gmbh |
Artificial fusion proteins with reduced immunogenicity
|
US7208147B2
(en)
*
|
2001-03-08 |
2007-04-24 |
Merck Patent Gmbh |
Modified granulocyte macrophage colony stimulating factor (GM-CSF) with reduced immunogenicity
|
WO2002074783A2
(en)
|
2001-03-15 |
2002-09-26 |
Merck Patent Gmbh |
Modified interferon beta with reduced immunogenicity
|
WO2002079415A2
(en)
*
|
2001-03-30 |
2002-10-10 |
Lexigen Pharmaceuticals Corp. |
Reducing the immunogenicity of fusion proteins
|
FR2823220B1
(fr)
*
|
2001-04-04 |
2003-12-12 |
Genodyssee |
Nouveaux polynucleotides et polypeptides de l'erythropoietine (epo)
|
US7271150B2
(en)
*
|
2001-05-14 |
2007-09-18 |
United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Modified growth hormone
|
US6833351B2
(en)
*
|
2001-05-21 |
2004-12-21 |
Douglas T. Dieterich |
Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US20030129203A1
(en)
*
|
2001-08-27 |
2003-07-10 |
Nautilus Biotech S.A. |
Mutant recombinant adeno-associated viruses
|
US7647184B2
(en)
*
|
2001-08-27 |
2010-01-12 |
Hanall Pharmaceuticals, Co. Ltd |
High throughput directed evolution by rational mutagenesis
|
CA2459138A1
(en)
*
|
2001-09-04 |
2003-03-13 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Modified human growth hormone
|
CA2403372A1
(en)
*
|
2001-09-13 |
2003-03-13 |
Intier Automotive Inc. |
Second row fold and pivot seat assembly
|
US6930086B2
(en)
*
|
2001-09-25 |
2005-08-16 |
Hoffmann-La Roche Inc. |
Diglycosylated erythropoietin
|
EP1507540A4
(de)
*
|
2001-10-10 |
2006-12-06 |
Centocor Inc |
Nukleinsäureimpfstoffe unter verwendung von tumorantigen-kodierenden nukleinsäuren mit einer cytokinadjuvans-kodierenden nukleinsäure
|
EP2042196B1
(de)
*
|
2001-10-10 |
2016-07-13 |
ratiopharm GmbH |
Neumodellierung und Glykokonjugation von Granulozyten-Kolonie stimulierender Faktor (G-CSF)
|
US6786634B2
(en)
*
|
2001-10-10 |
2004-09-07 |
Noritake Co., Limited |
Temperature measuring method and apparatus
|
US7297511B2
(en)
*
|
2001-10-10 |
2007-11-20 |
Neose Technologies, Inc. |
Interferon alpha: remodeling and glycoconjugation of interferon alpha
|
AU2002360349A1
(en)
*
|
2001-11-09 |
2003-05-26 |
Pharmacia And Upjohn Company |
Single nucleotide polymorphisms in gh-1
|
GB0127213D0
(en)
*
|
2001-11-12 |
2002-01-02 |
Univ Wales Medicine |
Method of detecting growth hormone variations in humans the variations and their uses
|
GB2384001B
(en)
*
|
2001-12-14 |
2004-02-04 |
Asterion Ltd |
Chimeric growth hormone-growth hormone receptor proteins
|
US20030224404A1
(en)
*
|
2002-02-25 |
2003-12-04 |
Manuel Vega |
High throughput directed evolution of nucleic acids by rational mutagenesis
|
CA2491567A1
(en)
|
2002-07-01 |
2004-01-08 |
The Kenneth S. Warren Institute, Inc. |
Recombinant tissue protective cytokines and encoding nucleic acids thereof for protection, restoration, and enhancement of responsive cells, tissues, and organs
|
US6809191B2
(en)
*
|
2002-07-03 |
2004-10-26 |
Vaxim, Inc. |
GM-CSF nucleic acid sequences
|
BR0313135A
(pt)
*
|
2002-08-09 |
2005-07-05 |
Merck Patent Gmbh |
Epìtopos de células t em eritropoietina
|
CN1684979A
(zh)
*
|
2002-08-31 |
2005-10-19 |
希杰株式会社 |
糖基化的人干扰素α同种型
|
US20060020396A1
(en)
*
|
2002-09-09 |
2006-01-26 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
CA2498319A1
(en)
*
|
2002-09-09 |
2004-03-18 |
Nautilus Biotech |
Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
|
US20050202438A1
(en)
*
|
2002-09-09 |
2005-09-15 |
Rene Gantier |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
AU2003267700A1
(en)
|
2002-09-09 |
2004-03-29 |
Nautilus Biotech |
Rational directed protein evolution using two-dimensional rational mutagenesis scanning
|
US20050176627A1
(en)
*
|
2002-09-09 |
2005-08-11 |
Anthony Cerami |
Long acting erythropoietins that maintain tissue protective activity of endogenous erythropoietin
|
CA2500626A1
(en)
|
2002-10-01 |
2004-04-15 |
Xencor, Inc. |
Interferon variants with improved properties
|
US20050054053A1
(en)
*
|
2002-10-01 |
2005-03-10 |
Xencor, Inc. |
Interferon variants with improved properties
|
US7189740B2
(en)
*
|
2002-10-15 |
2007-03-13 |
Celgene Corporation |
Methods of using 3-(4-amino-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myelodysplastic syndromes
|
US20040091961A1
(en)
*
|
2002-11-08 |
2004-05-13 |
Evans Glen A. |
Enhanced variants of erythropoietin and methods of use
|
WO2004046365A2
(en)
*
|
2002-11-18 |
2004-06-03 |
Maxygen, Inc. |
Interferon-alpha polypeptides and conjugates
|
US20040142870A1
(en)
*
|
2002-11-20 |
2004-07-22 |
Finn Rory F. |
N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
|
PA8588901A1
(es)
*
|
2002-11-20 |
2005-02-04 |
Pharmacia Corp |
Conjugados de hormona de crecimiento humana pegilados n-terminales y proceso para su preparacion
|
KR100541850B1
(ko)
|
2003-03-31 |
2006-01-11 |
삼성정밀화학 주식회사 |
인간 인터페론-베타 변이체 및 그의 제조방법
|
WO2005003157A2
(en)
|
2003-06-10 |
2005-01-13 |
Xencor, Inc. |
Interferon variants with improved properties
|
KR100632985B1
(ko)
*
|
2003-07-26 |
2006-10-11 |
메덱스젠 주식회사 |
생리활성 조절 단백질의 효능 향상 방법 및 그 예시변이체들
|
WO2005070138A2
(en)
*
|
2004-01-08 |
2005-08-04 |
Neose Technologies, Inc. |
O-linked glycosylation of peptides
|
EP1718664A4
(de)
*
|
2004-02-02 |
2008-08-13 |
Ambrx Inc |
Modifizierte menschliche vierhelix-bündel-peptide und ihre verwendungen
|
WO2005103076A2
(en)
|
2004-04-23 |
2005-11-03 |
Cambridge Antibody Technology Limited |
Erythropoietin protein variants
|
WO2005110465A2
(en)
|
2004-04-29 |
2005-11-24 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases
|
MX2007001589A
(es)
|
2004-08-09 |
2007-08-02 |
Alios Biopharma Inc |
Variantes de polipeptido resistentes a proteasa, hiperglicosiladas sinteticas, formulaciones orales y metodos para utilizar las mismas.
|
US20060073563A1
(en)
|
2004-09-02 |
2006-04-06 |
Xencor, Inc. |
Erythropoietin derivatives with altered immunogenicity
|
MX2007002557A
(es)
|
2004-09-03 |
2007-10-10 |
Creabilis Therapeutics Spa |
Uso de polipeptidos obtenidos a traves de mutaciones sistematicas de aminoacidos unicos de bloque-a humano y no humano de hmgb1 para prevenir y/o antagonizar las patologias inducidas por hmgb1.
|
US7998930B2
(en)
*
|
2004-11-04 |
2011-08-16 |
Hanall Biopharma Co., Ltd. |
Modified growth hormones
|
GB0500099D0
(en)
|
2005-01-05 |
2005-02-09 |
Cambridge Antibody Tech |
Methods and means relating to protein variants
|
EP1877434A2
(de)
|
2005-05-04 |
2008-01-16 |
Nautilus Biotech |
Modifizierte interferon-gamma-polypeptide und verfahren zur anwendung modifizierter interferon-gamma-polypeptide
|
WO2007110230A2
(en)
|
2006-03-27 |
2007-10-04 |
Institut Pasteur |
Secreted proteins as early markers and drug targets for autoimmunity, tumorigenesis and infections
|
WO2007110231A2
(en)
*
|
2006-03-28 |
2007-10-04 |
Nautilus Biotech, S.A. |
MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
|
EP2423306A1
(de)
|
2006-06-19 |
2012-02-29 |
Catalyst Biosciences, Inc. |
Modifizierte Gerinnungsfaktor-IX-Polypeptide und deren Verwendung bei der Behandlung
|
WO2008065372A2
(en)
|
2006-11-28 |
2008-06-05 |
Nautilus Biotech, S.A. |
Modified erythropoietin polypeptides and uses thereof for treatment
|
US20080260820A1
(en)
|
2007-04-19 |
2008-10-23 |
Gilles Borrelly |
Oral dosage formulations of protease-resistant polypeptides
|
ATE548381T1
(de)
|
2008-05-29 |
2012-03-15 |
Hanall Biopharma Co Ltd |
Modifizierte erythropoietin (epo)-polypeptide mit erhöhter proteaseresistenz und pharmazeutische zusammensetzungen daraus
|